Could Cutting DEI In Medicine Cost Lives? The High-Stakes Impact Of Trump’s Executive Order

With the FDA quietly rolling back DEI initiatives under Trump’s latest executive order, experts warn that underrepresentation in clinical research could put lives at risk—especially for marginalized communities.

Feb 2, 2025 - 12:52
 0
Could Cutting DEI In Medicine Cost Lives? The High-Stakes Impact Of Trump’s Executive Order
With the FDA quietly rolling back DEI initiatives under Trump’s latest executive order, experts warn that underrepresentation in clinical research could put lives at risk—especially for marginalized communities.